Vitamin D levels and cytokine profiles in patients with systemic lupus erythematosus

Lupus

Volumn 24, Issue 11, 2015, Pages 1191-1197

  Schneider, L ^a   Colar Da Silva, A C ^a   Werres Junior, L C ^a   Alegretti, A P ^a   Pereira Dos Santos, A S ^a   Santos, M ^a   Sassi, R ^a   Heemann, B ^a   Pfaffenseller, B ^a   Tavares Brenol, J C ^a   Monticielo, O A ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

25 hydroxyvitamin D; cytokine profile; systemic lupus erythematosus; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; ALPHA INTERFERON; ANALGESIC AGENT; ANTIMALARIAL AGENT; CYTOKINE; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 12; INTERLEUKIN 12P70; INTERLEUKIN 17; INTERLEUKIN 21; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; VITAMIN D; VITAMIN D RECEPTOR; 25-HYDROXYVITAMIN D;

ADULT; ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; GENETIC POLYMORPHISM; HUMAN; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEASONAL VARIATION; SLEDAI; SYSTEMIC LUPUS ERYTHEMATOSUS; TH1 CELL; TH1 TH2 BALANCE; TH17 CELL; TH2 CELL; VENEREAL DISEASE REACTION TEST; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; ANALOGS AND DERIVATIVES; BLOOD; CROSS-SECTIONAL STUDY; FLOW CYTOMETRY; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PREVALENCE; PROCEDURES; SEVERITY OF ILLNESS INDEX;

ADULT; CROSS-SECTIONAL STUDIES; CYTOKINES; FEMALE; FLOW CYTOMETRY; HUMANS; INTERFERON-ALPHA; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PREVALENCE; SEVERITY OF ILLNESS INDEX; TH1 CELLS; TH17 CELLS; TH2 CELLS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84941217617     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203315584811     Document Type: Article

References (42)

1. Uramoto KM, Michet CJ, Thumboo J, Sunku J, O'Fallon WM, Gabriel SE,. Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992. Arthritis Rheum 1999; 42: 46-50.
2. Kamen DL, Tangpricha V,. Vitamin D and molecular actions on the immune system: modulation of innate and autoimmunity. J Mol Med 2010; 88: 441-450.
3. Norman AW,. Sunlight, season, skin pigmentation, vitamin D, and 25-hydroxyvitamin D: integral components of the vitamin D endocrine system. Am J Clin Nutr 1998; 67: 1108-1110.
4. Qiao SW, Iversen R, Ráki M, Sollid LM,. The adaptive immune response in celiac disease. Semin Immunopathol 2012; 34: 523-540.
5. Arnson Y, Amital H, Shoenfeld Y,. Vitamin D and autoimmunity: new aetiological and therapeutic considerations. Ann Rheum Dis 2007; 66: 1137-1142.
6. Adorini L, Penna G,. Control of autoimmune diseases by the vitamin D endocrine system. Nat Clin Pract Rheumatol 2008; 4: 404-412.
7. Monticielo OA, Teixeira TeM, Chies JA, Brenol JC, Xavier RM,. Vitamin D and polymorphisms of VDR gene in patients with systemic lupus erythematosus. Clin Rheumatol 2012; 31: 1411-1421.
8. Souberbielle JC, Body JJ, Lappe JM,. Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: recommendations for clinical practice. Autoimmun Rev 2010; 9: 709-715.
9. Kamen DL, Aranow C,. The link between vitamin D deficiency and systemic lupus erythematosus. Curr Rheumatol Rep 2008; 10: 273-280.
10. Ritterhouse LL, Crowe SR, Niewold TB,. Vitamin D deficiency is associated with an increased autoimmune response in healthy individuals and in patients with systemic lupus erythematosus. Ann Rheum Dis 2011; 70: 1569-1574.
11. Reiner SL,. Development in motion: helper T cells at work. Cell 2007; 129: 33-36.
12. Aranow C,. Vitamin D and the immune system. J Invest Med 2011; 59: 881-886.
13. Alvarez-Rodriguez L, Lopez-Hoyos M, Garcia-Unzueta M, Amado JA, Cacho PM, Martinez-Taboada VM,. Age and low levels of circulating vitamin D are associated with impaired innate immune function. J Leukoc Biol 2012; 91: 829-838.
14. Alroy I, Towers TL, Freedman LP,. Transcriptional repression of the interleukin-2 gene by vitamin D3: direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor. Mol Cell Biol 1995; 15: 5789-5799.
15. Lemire JM, Adams JS, Kermani-Arab V, Bakke AC, Sakai R, Jordan SC,. 1,25-Dihydroxyvitamin D3 suppresses human T helper/inducer lymphocyte activity in vitro. J Immunol 1985; 134: 3032-3035.
16. Daniel C, Sartory NA, Zahn N, Radeke HH, Stein JM,. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile. J Pharmacol Exp Ther 2008; 324: 23-33.
17. Hochberg MC,. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725-1725.
18. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH,. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992; 35: 630-640.
19. Gladman D, Ginzler E, Goldsmith C,. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996; 39: 363-369.
20. O'Regan S, Chesney RW, Hamstra A, Eisman JA, O'Gorman AM, Deluca HF,. Reduced serum 1,25-(OH)2 vitamin D3 levels in prednisone-treated adolescents with systemic lupus erythematosus. Acta Paediatr Scand 1979; 68: 109-111.
21. Sahebari M, Nabavi N, Salehi M,. Correlation between serum 25(OH)D values and lupus disease activity: an original article and a systematic review with meta-analysis focusing on serum VitD confounders. Lupus 2014; 23: 1164-1177.
22. Premaor MO, Paludo P, Manica D,. Hypovitaminosis D and secondary hyperparathyroidism in resident physicians of a general hospital in southern Brazil. J Endocrinol Invest 2008; 31: 991-995.
23. Scalco R, Premaor MO, Fröehlich PE, Furlanetto TW,. High prevalence of hypovitaminosis D and secondary hyperparathyroidism in elders living in nonprofit homes in South Brazil. Endocrine 2008; 33: 95-100.
24. Bikle D,. Nonclassic actions of vitamin D. J Clin Endocrinol Metab 2009; 94: 26-34.
25. Yusupov E, Li-Ng M, Pollack S, Yeh JK, Mikhail M, Aloia JF. Vitamin D and serum cytokines in a randomized clinical trial. Int J Endocrinol 2010; 2010. DOI: 10.1155/2010/305054.
26. Jeffery LE, Burke F, Mura M,. 1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. J Immunol 2009; 183: 5458-5467.
27. Dolff S, Bijl M, Huitema MG, Limburg PC, Kallenberg CG, Abdulahad WH,. Disturbed Th1, Th2, Th17 and T(reg) balance in patients with systemic lupus erythematosus. Clin Immunol 2011; 141: 197-204.
28. Lit LC, Wong CK, Li EK, Tam LS, Lam CW, Lo YM,. Elevated gene expression of Th1/Th2 associated transcription factors is correlated with disease activity in patients with systemic lupus erythematosus. J Rheumatol 2007; 34: 89-96.
29. Wang Y, Ito S, Chino Y,. Laser microdissection-based analysis of cytokine balance in the kidneys of patients with lupus nephritis. Clin Exp Immunol 2010; 159: 1-10.
30. Elewa EA, Zakaria O, Mohamed EI, Boghdadi G,. The role of interleukins 4, 17 and interferon gamma as biomarkers in patients with systemic lupus erythematosus and their correlation with disease activity. Egypt Rheumatol 2014; 36: 21-27.
31. Terrier B, Derian N, Schoindre Y,. Restoration of regulatory and effector T cell balance and B cell homeostasis in systemic lupus erythematosus patients through vitamin D supplementation. Arthritis Res Ther 2012; 14: R221-R221.
32. Amital H, Szekanecz Z, Szücs G,. Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D? Ann Rheum Dis 2010; 69: 1155-1157.
33. Petri M, Bello KJ, Fang H, Magder LS,. Vitamin D in systemic lupus erythematosus: modest association with disease activity and the urine protein-to-creatinine ratio. Arthritis Rheum 2013; 65: 1865-1871.
34. Borba VZ, Vieira JG, Kasamatsu T, Radominski SC, Sato EI, Lazaretti-Castro M,. Vitamin D deficiency in patients with active systemic lupus erythematosus. Osteoporos Int 2009; 20: 427-433.
35. Dall'era MC, Cardarelli PM, Preston BT, Witte A, Davis JC,. Type I interferon correlates with serological and clinical manifestations of SLE. Ann Rheum Dis 2005; 64: 1692-1697.
36. Feng X, Wu H, Grossman JM,. Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus. Arthritis Rheum 2006; 54: 2951-2962.
37. Obermoser G, Pascual V,. The interferon-alpha signature of systemic lupus erythematosus. Lupus 2010; 19: 1012-1019.
38. Harigai M, Kawamoto M, Hara M, Kubota T, Kamatani N, Miyasaka N,. Excessive production of IFN-gamma in patients with systemic lupus erythematosus and its contribution to induction of B lymphocyte stimulator/B cell-activating factor/TNF ligand superfamily-13B. J Immunol 2008; 181: 2211-2219.
39. Postal M, Peliçari KO, Sinicato NA, Marini R, Costallat LT, Appenzeller S,. Th1/Th2 cytokine profile in childhood-onset systemic lupus erythematosus. Cytokine 2013; 61: 785-791.
40. Qian Q, Li P, Wang T,. Alteration of Th1/Th2/Th17 cytokine profile and humoral immune responses associated with chromate exposure. Occup Environ Med 2013; 70: 697-702.
41. Tucci M, Lombardi L, Richards HB, Dammacco F, Silvestris F,. Overexpression of interleukin-12 and T helper 1 predominance in lupus nephritis. Clin Exp Immunol 2008; 154: 247-254.
42. Abou-Raya A, Abou-Raya S, Helmii M,. The effect of vitamin D supplementation on inflammatory and hemostatic markers and disease activity in patients with systemic lupus erythematosus: a randomized placebo-controlled trial. J Rheumatol 2013; 40: 265-272.